{"title":"Dose-Dependent Improvement of Caffeic Acid Against Acrylamide-Induced Male Reproductive Dysfunction","authors":"Divya Gupta, Sadhana Shrivastava, Sangeeta Shukla","doi":"10.1002/ddr.70103","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Dietary exposure to acrylamide is almost unavoidable and may result into long-term consequences. It has been reported to cause sexual dysfunction and even infertility. This study aimed to investigate the protective effects of caffeic acid against acrylamide-induced reproductive dysfunction in male rats. Group 1 served as the control; group 2 received acrylamide at a dose of 40 mg/kg for 10 days. In groups, 3–6, acrylamide was given as in group 2, followed by therapy of caffeic acid (10, 20, 30, 40 mg/kg) for 3 consecutive days. It was found that acrylamide causes significant alteration in serum concentrations of FSH, testosterone, and LH; decreased sperm motility and viability. Acrylamide administration causes alteration in biochemical parameters including lipid peroxidation, reduced glutathione, and antioxidant enzymes (SOD and CAT) along with triglyceride, cholesterol, and seminal fructose. Moreover, acrylamide causes histological alterations and promotes DNA damage as evident by COMET assay. After caffeic acid treatment, serological, biochemical, and histological alterations returned to almost normal ranges. Based on our findings, it is reasonable to conclude that caffeic acid, a natural antioxidant, is a potential medication to lessen any harmful damage in male gonads brought on by acrylamide consumption.</p>\n </div>","PeriodicalId":11291,"journal":{"name":"Drug Development Research","volume":"86 4","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ddr.70103","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Dietary exposure to acrylamide is almost unavoidable and may result into long-term consequences. It has been reported to cause sexual dysfunction and even infertility. This study aimed to investigate the protective effects of caffeic acid against acrylamide-induced reproductive dysfunction in male rats. Group 1 served as the control; group 2 received acrylamide at a dose of 40 mg/kg for 10 days. In groups, 3–6, acrylamide was given as in group 2, followed by therapy of caffeic acid (10, 20, 30, 40 mg/kg) for 3 consecutive days. It was found that acrylamide causes significant alteration in serum concentrations of FSH, testosterone, and LH; decreased sperm motility and viability. Acrylamide administration causes alteration in biochemical parameters including lipid peroxidation, reduced glutathione, and antioxidant enzymes (SOD and CAT) along with triglyceride, cholesterol, and seminal fructose. Moreover, acrylamide causes histological alterations and promotes DNA damage as evident by COMET assay. After caffeic acid treatment, serological, biochemical, and histological alterations returned to almost normal ranges. Based on our findings, it is reasonable to conclude that caffeic acid, a natural antioxidant, is a potential medication to lessen any harmful damage in male gonads brought on by acrylamide consumption.
期刊介绍:
Drug Development Research focuses on research topics related to the discovery and development of new therapeutic entities. The journal publishes original research articles on medicinal chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, and drug delivery, formulation, and pharmacokinetics. The journal welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy, and regulatory issues involving the drug discovery and development process. In addition to full-length articles, Drug Development Research publishes Brief Reports on important and timely new research findings, as well as in-depth review articles. The journal also features periodic special thematic issues devoted to specific compound classes, new technologies, and broad aspects of drug discovery and development.